Prospects for Use of Incretin Mimetics in Metabolically Associated Fatty Liver Disease
Aim. To review current data on the effect of incretin mimetics on the course of metabolically associated fatty liver disease. Key points. In obesity, the liver is exposed to the negative effects of excessive lipid accumulation. This process underlies metabolically associated liver disease (MAFLD), a condition that ent...